AstraZeneca AZD9150 Mechanism of Action

First Page		Document Content
Date: 2014-05-12 12:58:34 Signal transduction RNA Molecular genetics Transcription factors STAT3 Mammalian target of rapamycin Messenger RNA Large-cell lymphoma Hepatocellular carcinoma Biology Biochemistry Gene expression		AstraZeneca AZD9150 Mechanism of Action Add to Reading List Source URL: www.ncats.nih.gov Download Document from Source Website File Size: 96,82 KB Share Document on Facebook

	A Pharmacological Map of the PI3-K Family Defines a Role for p110a in Insulin Signaling Zachary A. Knight,1 Beatriz Gonzalez,4,7 Morri E. Feldman,1 Eli R. Zunder,1 David D. Goldenberg,2 Olusegun Williams,1 Robbie Loewith DocID: 1gum6 - View Document
	MATEC Web of Conferences 4, DOI: matecconf C Owned by the authors, published by EDP Sciences, 2013 DocID: 1gmrZ - View Document
	mTOR Signalling in Health and Disease A brief history of TOR Robbie Loewith1 Department of Molecular Biology, National Centres of Competence in Research ‘Frontiers in Genetics’ and ‘Chemical Biology’, University DocID: 1gjIY - View Document
	By Oana Tudor, version 1, January 2012 Guidelines for Manual Annotation for eFIP evaluation 1. The Purpose of eFIP The purpose of eFIP is to find abstracts refering to protein-protein interactions (PPIs) involving phosph DocID: 1gibr - View Document
	Press release Embargo: May 28, 2015, 12:00 noon US Eastern Time A new tool to study an important anti-cancer and immunosuppressive target Structure explains why protein becomes insensitive to its inhibitor rapamycin DocID: 1gfmY - View Document